Pelthos Therapeutics PTHS
NYSE PTHS
$25.51 -1.15 (-4.31%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pelthos Therapeutics (PTHS) Tax Provisions (2025)

Pelthos Therapeutics (PTHS) posted quarterly Tax Provisions of -$6.9 million for Q4 2025, down 1388.6% quarter-over-quarter from -$465000.0 in Q3 2025.

Pelthos Therapeutics (PTHS) Tax Provisions (2025) Analysis & Trends

Pelthos Therapeutics' Tax Provisions history runs 1 years deep, the most recent figure standing at -$6.9 million for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 59.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 15.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 75.45 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 13.31 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -90.33 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.90 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Pelthos Therapeutics 91.09 Mn 66.53 Mn 21.23 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.92 Mn
Sep 30, 2025 -465,000.00